About R-Tech Ueno
R-Tech Ueno is a Healthcare company based in Tokyo (Japan) founded in 1989, and was acquired by Sucampo in August 2015. Novel drugs are developed and manufactured for various disease areas. Its focus areas include Diversified Pharmaceuticals, Biopharma Outsourcing, CDMO and Small Molecules & Peptides.
Company details
As of 3 Dec 2015, R-Tech Ueno was acquired by Sucampo. At the time of the acquisition, R-Tech Ueno was a publicly traded company listed on the Tokyo Stock Exchange. The company focused on RD and marketing of drugs, targeting diseases that previously had no effective therapeutic agent. R-Tech Ueno is focused on promoting the development of new drugs focusing on three areas: drugs for unmet medical needs and eligible for government support, drugs for orphan diseases, and drugs that focus on diseases of the aging population. R-Tech manufactures the constipation drug Amitiza for Sucampo and partners including Takeda Pharmaceutical Co. and Mylan NV. It also has a pipeline of drug candidates in various stages of development in areas such as gastroenterology, ophthalmology, and autoimmune and inflammatory diseases.
- Headquarters Tokyo, Japan
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website rtechueno.com
- Acquired by Sucampo (Aug 2015)
Investors in R-Tech Ueno
R-Tech Ueno has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sucampo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Prostone-based drugs are developed for gastrointestinal, ophthalmic, and oncology disorders. | 1996 | sucampo.com | Rockville, United States |
Investor details for R-Tech Ueno
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of R-Tech Ueno
2 dated milestones of R-Tech Ueno across 26 years, from founding to its latest funding, stage changes and deals.
- Founded R-Tech Ueno is founded.
- Exit Acquired by Sucampo.
Web traffic of R-Tech Ueno
Websites that share an audience with R-Tech Ueno (rtechueno.com).
Websites whose visitors overlap most with R-Tech Ueno. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
eye.pfizer.co.jp | eye.pfizer.co.jp | 100% | – | ||
| carnabio.com | 97% | 21.3K | #1,167,012 | View details | |
fri.fujifilm.co.jp | fri.fujifilm.co.jp | 90% | – | ||
matsuura-kp.co.jp | matsuura-kp.co.jp | 90% | – | ||
dresources.jp | dresources.jp | 90% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for R-Tech Ueno
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about R-Tech Ueno
Complete news archive for R-Tech Ueno
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about R-Tech Ueno
R-Tech Ueno was founded in 1989.
R-Tech Ueno is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
As of 3 Dec 2015, R-Tech Ueno was acquired by Sucampo. At the time of the acquisition, R-Tech Ueno was a publicly traded company listed on the Tokyo Stock Exchange. The company focused on RD and marketing of drugs, targeting diseases that previously had no effective therapeutic agent. R-Tech Ueno is focused on promoting the development of new drugs focusing on three areas: drugs for unmet medical needs and eligible for government support, drugs for orphan diseases, and drugs that focus on diseases of the aging population. R-Tech manufactures the constipation drug Amitiza for Sucampo and partners including Takeda Pharmaceutical Co. and Mylan NV. It also has a pipeline of drug candidates in various stages of development in areas such as gastroenterology, ophthalmology, and autoimmune and inflammatory diseases.
R-Tech Ueno has 1 investor. Key investors include Sucampo.
Yes. R-Tech Ueno was acquired by Sucampo in August 2015.